对新诊断的55例T2DM患者随机分成对照组1日2次皮下注射甘舒霖30R治疗,治疗组在对照组基础上加二甲双胍治疗。12周后。结果两组空腹血糖、餐后2小时血糖、HbA1c均好转,但治疗组BMI无明显增加,血糖达标时间短,胰岛素用量少,低血糖发生率低。结论预混胰岛素联合二甲双胍治疗新诊断T2DM是一种较好的方法。 The newly diagnosed 55 T2DM patients were randomly divided into control group 2 times on the 1st subcutaneous injection of Gan Shu Lin 30R treatment, the treatment group in the control group based on the metformin treatment. After 12 weeks. Results The fasting blood glucose, HbA1c in 2 hours after meal were all improved in both groups, but the BMI in the treatment group was not significantly increased, the time for achieving blood glucose was short, the dosage of insulin was low and the incidence of hypoglycemia was low. Conclusion Pre-mixed insulin and metformin in the treatment of newly diagnosed T2DM is a better method.